Skip to content
OpenCapital
Get started

Matinas BioPharma MTNB Q2 2025 earnings

Reported August 14, 2025 · Before market open

EPS-$1.03

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$25.0K
EPS estimate-$1.50

Versus estimates

Revenue

Q4 2024$962.0K

Diluted EPS

Q1 2026-$0.30Beat by $1.02Q4 2025-$0.24Beat by $1.08Q3 2025-$0.40
Q2 2025-$1.03
Q1 2025-$1.68Miss by $0.90Q4 2024-$1.50Miss by $0.72

Ask the moment Matinas BioPharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Matinas BioPharma report Q2 2025 earnings?
Matinas BioPharma (MTNB) reported Q2 2025 earnings on August 14, 2025 before market open.
What were Matinas BioPharma's Q2 2025 revenue and EPS?
Matinas BioPharma reported eps of $-1.03 for Q2 2025.
How did Matinas BioPharma's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 3.0% from $-1.00.
Where can I find Matinas BioPharma's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001641172-25-024014) directly on SEC EDGAR. The filing index links above go to sec.gov.